Running head: LEARNING MANAGEMENT ANALYSIS
LEARNING MANAGEMENT ANALYSIS
Learning Management Analysis
Larry Ratliff Jr
April 22, 2018
Dr. Manuel Johnican
LEARNING MANAGEMENT ANALYSIS
Seattle genetics is a biotechnological company that is focused on developing of the antibody-based therapies to help in the treatment of cancer. The company is located in Bothell, Washington and have more than 800 employees. In the company, the onset training courses to enhance the jib related skills, tuition reimbursement and access to conference and the seminars. The company encourages and supports the continuing education and offer the job-related trainings. The company is focused to help the employees who are constantly striving to attain the individual goals and recognizing the power of collaborative working. In the same regard the company assists the employees by offering the molecular medicine programs.
The molecular medicine training programs the medical training program that aims at training students to work at the basic medicine and science by enabling them carry out a translated research that meets higher standards of the medical significance and scientific rigor. The students who complete the training come out with the intellectual experience and tools in the clinical environments to create new comprehensive and imaginative solutions to major medicine issues. (Steinberg, & Jordan, 2012). The graduates will comprise the new cadre of the scientists by being able to apply the cutting age experimental strategies in solving important questions in the health of humans and diseases and to conversely use insights from the human disease processes in solving fundamental problems which occur biologically.
Education system used
The company is specifically focused in educating the professionals since it is viewed that integrating genetics to curriculum and training of the health professionals are the critical needs. In response to the training, the organization implemented the integrated curricular and the offer options to genetic curriculum compositions. (Deeds, DeCarolis, & Coombs, 2013). The faculty is capable of teaching genetics where genetics in education materials is included and effective approaches to educate the professionals of health of the relevance of genetics and enabling them to have an understanding of the impacts of educational programs on clinical practices. The strategies of achieving all the goals include additional funding, provision of the faculties with the professional’s experts, involving the educators with the diverse backgrounds, supporting curricular development, improving access to one genetics education activities and demonstration of the relevance of clinical genetics.
Education stakeholders’ administration ensuring the success of the training
The training is controlled by the secretary advisory committee on genetics, health, and society SACGHS. The training is also engineered by the human and health resource management as the public forum deliberation on the wide ranges of the policy issues that are raised by the use and development of genetics tests as it is warranted in providing that advice concerning the issues like cancer treatment methods. The charter is focused on the following roles:
· By taking a study on the public health, the clinical health, economic, ethical, societal and legal implications of the genomic and genetic applications and technologies in an organization will be also the fatal role of the committee.
· Assessing how the genomic and Genetic technologies are being integrated into public health and health care.
· Analyzing the uses of genetics information in education, law, employment and insurance.
· Identifying the opportunities and the gaps in the research and the collection and analysis efforts.
· Examining the impact of the patent policy and the license parties in the access of the genomic and genetic technologies.
· Serving as the public law and forum of the issues raised by the genomic and genetic technologies.
· Identify the opportunities and the gaps in data collection and analysis and research efforts.
Needs those stakeholders require in accomplishing their roles in the training.
1. The committee should provide a lasting framework that will help in addressing the new developments in the ongoing integration of genetics to clinical practice and public health by providing advice on the range of complex issues raised the new technological developments in human genetics and produces a body of work. This framework will be used by the trainees in educating on how address the issues affecting data collection as per the education system is enhanced.
2. The stakeholders should have an expertise in disciplines relevant to genomic and genetics technologies. These disciplines, human genetics, healthcare delivery, biomedical sciences, public health, evidence-based practice, social sciences, health policy, health services research, law, health disparities, ethics, economics, health care financing, consumer issues and other relevant fields. This expertise is believed to have necessary skills required to make the training a success and give the quality research on how to come up with health solutions.
3. The stakeholders should have members who have knowledge on consumer issues and concerns and the perspectives of the public in general. These members will enable the genetics research to be as easy since the company will be in a position to know the sides that need to be collected and the general knowledge of the consumers and how they react with the products. This information will help the company to offer trainings basing on the needs of the consumers.
4. Throughout the training, the work of the committee and the representatives of the relevant departments should participate in the SACGHS in a nonvoting capacity. The departments should include the department of defense, departments of commerce, department of education, department of energy, justice, labor and equal employment commission. The departments will serve as a hiding tool too helps education to be conducted in the right procedure.
5. The stakeholders should form a genetics education and the training task forces which will help them identify the education and the training issues which are pertinent to:
· The primary health care professionals like the family practice physician, nurses, pediatricians, genetic counselors and the pharmacists.
· The public health providers likely to be involved in the services
· Consumers and the patients
Priorities on the needs of the stakeholders
The committee should prioritize on the provision of ranges of advice on the new technological developments so as to provide a range of lasting framework in the ongoing integration of genetics to clinical practice and public health. Prioritizing on the same will enhance the company to have the required knowledge of the new technological advancements and this will help the company to have a well-planned training and some focused ideas.
The company also should prioritize on the selection of the members with the knowledgeable consumer’s demands and skills. This will help the company to offer trainings on the parts which are more demanding and helpful to the students so as to have the necessary skills in the outside market and preferences.
Strategies in assessing proprietary and open access to LMS
In order to achieve the desired goals on achieving the satisfactory needs of the company, the management should put into consideration a number of factors that will enhance proper and easy achievement of the needs of the organizations. The following key factors should be put into consideration:
Open source vs. Proprietary LMS
To differentiate between the open source and the proprietary of the learning management system, the management should look at the key cost differences between the proprietary and closes and open source solutions like the noodle LMS. As a result, the management should look if to use the fee to achieve the desired goals or not. The fee will be in form of paying for the license per use in every perpetual service. In addition, the functionaries available of new in the new versions to implement and also save and a bit of thought on how will it best take the new features.
The open sources are free but some costs are still incurred. The costs will be incurred in that, the adoption of the new noodle of today will lead to buy the software which is free but it will require trained persons to learn them. In that regard, the company will be required to conduct training to its employees so as to be well equipped with necessary skills of the new advanced technology before purchasing of the software. This will actually reduce spending of unnecessary costs.
The management also should consider beyond the costs. In assessing whether the open source system or the proprietary is better for an organization, to go beyond the costs. Taking into consideration the risks associated with the proprietary product disruption since of a merger or the collapse of the open source systems will provide slower risk options because the code belongs to everyone. Moreover, since many developers can assess the core, bugs get quickly fixed for the security patch to release and continuously upgrade the features. This will help the organization to market its products.
Deeds, D. L., DeCarolis, D., & Coombs, J. (2000). Dynamic capabilities and new product development in high technology ventures: An empirical analysis of new biotechnology firms. Journal of Business venturing, 15(3), 211-229
Ozdemir, V., Pang, T., Knoppers, B. M., Avard, D., Faraj, S. A., Zawati, M. N. H., & Kolker, E. (2015). Vaccines of the 21st century and vaccinomics: data-enabled science meets global health to spark collective action for vaccine innovation
Steinberg, E. K., & Jordan, C. E. (2012). Using molecular genetics to learn about the ecology of threatened species: the allure and the illusion of measuring genetic structure in natural populations. In Conservation biology (pp. 440-460). Springer, Boston, MA.
Schadt, E. E., Linderman, M. D., Sorenson, J., Lee, L., & Nolan, G. P. (2014). Computational solutions to large-scale data management and analysis. Nature Reviews Genetics, 11(9), 647.